611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
Health Tip: Treating ScoliosisGot Knee Pain? What You Need to Know About Alternatives to SurgeryRoundup Linked to Human Liver Damage: StudyNew Gene Variants for Type 2 Diabetes FoundBipolar Disorder a Risk Factor for Parkinson's?Many 'Dehumanize' People with ObesityHeart Attack Treatment Could Cut 'Bad' Cholesterol by Half Within HoursFewer Deaths Tied to Dirty Air, But Threats Persist: ReportAggressive Approach to Pancreatic Cysts May Prevent Dreaded CancerBlood Banks Could Help Screen for Hereditary High CholesterolHealth Tip: Living With Leg SwellingQ Fever? A Bigger Threat to Humans Than ThoughtFor Many With Mild Asthma, Popular Rx May Not Work: StudyCleaner Air Linked to Lower Asthma Rates in KidsCholesterol Levels Improving Among U.S. KidsPool Chemicals Harm Thousands Every SummerAre Diets High in Processed Foods a Recipe for Obesity?Lupus Takes Bigger Toll on Longevity for BlacksScientists Spot Unexpected Player in FibromyalgiaAnthrax Is a Risk on Every ContinentAHA News: More Clues to the Genetics Behind an Inherited Cholesterol DisorderSuspect Your Child Has an Ear Infection? There May Soon Be an App for ThatLyme Disease Now a Threat in City Parks Health Tip: Treating a Charley HorseMore Back-to-Back Heat Waves Will Come With Climate ChangeParents, Here's How to Protect Your Child During Measles OutbreaksAHA News: Dangerous Blood Clots May Be the Latest Risk From 'Bad' CholesterolAre You Running Short on Iron?1 in 4 American Workers Struggles With Back PainInjured Lungs Can Be Regenerated for Transplant: StudyKeeping Your Summer Fun on Sound FootingMore Active Lupus Linked to Childhood EventsSigns of Rheumatoid Arthritis Can Show Up Long Before DiagnosisSummer Is Tough for Asthma SufferersHepatitis A Infections Soaring: CDCIs the County You Call Home a Potential Measles Hotspot?'Zap' Ear Clip May Ease A-FibTake Steps to Prevent a StrokeDoes Removing Your Appendix Put You at Risk for Parkinson's?Potentially Blinding Shingles of the Eye on the RisePsoriasis, Mental Ills Can Go Hand in HandAfter Concussions, Some Ex-Athletes Show Key Marker for Brain Disease: StudyWindow for Safe Use of Clot-Buster Widens for Stroke PatientsAn Antibiotic Alternative? Using a Virus to Fight BacteriaDo Adults Need a Measles Booster Shot?Military Tourniquets Might Save Kids' Lives During School ShootingsWell Water's Spillover Effect: Heart Damage?AHA News: Helping Asian-Americans Fight Their Hidden Heart RisksSunscreen Chemicals Enter Bloodstream at Potentially Unsafe Levels: Study'Ringing in the Ears' May Drive Some to the Brink of Suicide
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Window for Safe Use of Clot-Buster Widens for Stroke Patients

HealthDay News
by By Amy NortonHealthDay Reporter
Updated: May 8th 2019

new article illustration

WEDNESDAY, May 8, 2019 (HealthDay News) -- For years, many people suffering a stroke have not been able to get a critical drug due to time limits on its use. Now, a new study suggests that treatment time window can be doubled.

Experts said the findings could open up the treatment option for many more stroke victims.

The drug is called tissue plasminogen activator, or tPA. It can dissolve the blood clot causing a person's stroke, and protect brain tissue from any further damage. However, tPA has to be given within a certain time frame to work.

Long-time guidelines stated that the drug should be infused within three hours of the first stroke symptoms -- or, for certain patients, within 4.5 hours.

That has limited its use. One problem is that people often do not recognize the signs of a stroke and delay going to the hospital, explained Dr. Randolph Marshall, a professor of neurology at Columbia University, in New York City.

He wrote an editorial published with the study.

Another issue is that some people wake up in the midst of a stroke, and it's unclear when the symptoms began.

So, at least as of 2013, only about 6% of patients hospitalized for an ischemic stroke received tPA, according to Marshall.

Ischemic strokes are caused by a clot that blocks blood flow to the brain, and they account for the large majority of all strokes.

In the new trial, researchers looked at whether they could expand the tPA time frame to nine hours in certain ischemic stroke patients. Specifically, that meant cases where brain imaging showed the drug could still be beneficial.

The study took advantage of a newer technology called "perfusion" imaging.

"It allows us to see the area of brain damage, and whether there is still tissue that's salvageable," Marshall explained. It's done using either a CT or MRI scanner.

When patients did have savable brain tissue, the trial found, giving tPA as late as nine hours after the first symptoms still brought benefits. Three months later, over 35% of those patients had no or minimal disability from their stroke.

That compared with 29.5% of patients who were given infusions of a placebo (along with other standard stroke care).

The benefit did come at a price. About 6% of tPA patients had bleeding in the brain -- a known side effect of the drug. But that figure is similar to what's seen when tPA is given earlier, too, Marshall pointed out.

Dr. Geoffrey Donnan, a neurologist at the University of Melbourne, in Australia, led the study.

He said the findings suggest that perfusion imaging should be done whenever a stroke patient either woke up with symptoms, or can be treated within 4.5 to nine hours of their first symptoms.

Perfusion imaging is not universally available, though. Right now, it's mainly used at larger hospitals with comprehensive stroke care, according to Marshall.

The findings are based on 225 stroke patients at hospitals in Australia, Taiwan and New Zealand. All underwent perfusion imaging and were shown to have savable brain tissue. Donnan's team randomly assigned them to have an infusion of either tPA or a placebo fluid.

Many of the patients had woken up with stroke symptoms. Others were known to have suffered their first symptoms within 4.5 to nine hours of being randomly assigned to their treatment.

Still, tPA is not the only stroke treatment option. Doctors can also physically remove the blood clot, using a scope that's threaded into the blocked brain artery. In fact, that procedure -- called a thrombectomy -- can be done as late as 24 hours after the first symptoms in some patients.

It's not known whether giving tPA in the later window would be preferable to a thrombectomy, according to Marshall.

"I think that will be the next big trial -- to compare this with thrombectomy," he said.

For now, Marshall and Donnan both stressed that people should learn the signs and symptoms of stroke, and never delay medical care.

The most common symptoms include sudden weakness or numbness in the face or arm (usually on one side of the body), slurred speech, and sudden difficulty walking or seeing, according to the American Stroke Association.

More information

The American Stroke Association has more on stroke treatment.